FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,835,490 | +29.1% | 5,818,804 | -4.0% | 0.54% | +43.0% |
| Q2 2023 | $20,011,606 | +27.4% | 6,064,123 | +10.0% | 0.38% | +16.5% |
| Q1 2023 | $15,708,741 | -56.8% | 5,511,839 | +10.4% | 0.33% | -55.9% |
| Q4 2022 | $36,351,071 | +12.7% | 4,993,279 | +25.3% | 0.74% | -0.1% |
| Q3 2022 | $32,246,000 | +66.1% | 3,985,910 | +0.6% | 0.74% | +48.3% |
| Q2 2022 | $19,410,000 | -77.3% | 3,961,194 | +9.7% | 0.50% | -71.7% |
| Q1 2022 | $85,405,000 | +24.9% | 3,611,194 | -6.6% | 1.77% | +77.0% |
| Q4 2021 | $68,405,000 | -37.1% | 3,866,872 | +0.3% | 1.00% | -39.1% |
| Q3 2021 | $108,758,000 | +223.8% | 3,855,291 | +20.3% | 1.64% | +223.5% |
| Q2 2021 | $33,591,000 | -11.0% | 3,205,291 | 0.0% | 0.51% | -13.9% |
| Q1 2021 | $37,758,000 | +55.7% | 3,205,291 | +54.7% | 0.59% | +44.7% |
| Q4 2020 | $24,256,000 | +165.8% | 2,071,409 | +80.0% | 0.41% | +85.0% |
| Q3 2020 | $9,124,000 | – | 1,150,565 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |